Contact: Jennifer Beal sciencenewsroom@wiley.com 44-012-437-70633 Wiley People with hepatitis C and chronic liver disease who relapsed or failed to respond to initial treatment are unlikely to improve on interferon retreatment. In fact, they may face an increased risk of dying… Read More ›
Interferon
HALT-C researchers: Interferon as long-term treatment for hepatitis C not effective
2008 study posted for filing Contact: LaKisha Ladson lakisha.ladson@utsouthwestern.edu 214-648-3404 UT Southwestern Medical Center IMAGE:Dr. William M. Lee and other researchers have discovered in a multicenter study that using the drug interferon as a long-term maintenance strategy to slow the… Read More ›
Interferon does not slow or stop hepatitis C from worsening, study finds
Interferon does not slow or halt the progression of chronic hepatitis C and advanced liver disease in patients who haven’t responded to previous attempts to eradicate the disease, a national study in which the Saint Louis University School… Read More ›
Hepatitis A and or B Gives greater chance to recover from Hep C..Plus Morphine increases HCV Replication
Contact: Lixin Zhu wjg@wjgnet.com 86-108-538-1892 World Journal of Gastroenterology Who will recover spontaneously from hepatitis C virus infection More than 3% of world population is infected with hepatitis C virus (HCV). The outcome of HCV infections is either self recovery… Read More ›
Widely prescribed MS treatment may not slow progression of disease: VCH-UBC research
Researchers with the UBC Hospital MS Clinic and Brain Research Centre at Vancouver Coastal Health and the University of British Columbia have published important data in the Journal of the American Medical Association (JAMA) about the impact of a common… Read More ›
Engineering Evil 